Old Web
English
Sign In
Acemap
>
Paper
>
Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26
Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26
2017
S. Karim
Keyue Ding
Penelope A. Bradbury
Peter M. Ellis
N. Mittman
X. Xiaoqun Sun
Michael Millward
Geoffrey Liu
Sophie Sun
Martin R. Stockler
V. Cohen
Normand Blais
Randeep Sangha
Michael Boyer
R. Sasidharan
Chee Khoon Lee
Frances A. Shepherd
G. Goss
Lesley Seymour
Natasha B. Leighl
Keywords:
General surgery
Medicine
Placebo
Dacomitinib
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]